Screener
Amneal Pharmaceuticals, Inc. AMRX Specialty — Operating Income (Loss)
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Amneal Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001723128-26-000031
| Three Months Ended June 30, 2026 | Affordable Medicines (1) | Specialty | Av KARE | Corporateand Other | Total Company |
|---|---|---|---|---|---|
| Selling, general and administrative | 42,367 | 40,095 | 16,913 | 49,347 | 148,722 |
| Research and development | 33,023 | 5,994 | — | — | 39,017 |
| Intellectual property legal development expenses | 2,002 | 85 | — | — | 2,087 |
| Acquisition costs | — | — | — | 7,600 | 7,600 |
| Restructuring and other charges | — | — | — | 554 | 554 |
| Charges related to legal matters, net | 8,057 | — | — | — | 8,057 |
| Other operating income | (1,298) | — | — | — | (1,298) |
| Operating income (loss) | $123,078 | $54,856 | $9,336 | $(57,501) | $129,769 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Amneal Pharmaceuticals, Inc.'s specialty — operating income (loss)?
- Amneal Pharmaceuticals, Inc. (AMRX) reported specialty — operating income (loss) of $54.86M in Q2 2026.
- How has Amneal Pharmaceuticals, Inc.'s specialty — operating income (loss) changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s specialty — operating income (loss) increased by 54.6% year-over-year, from $35.49M to $54.86M.
- What does specialty — operating income (loss) mean?
- Measures the core profitability of the specialty segment by subtracting operating expenses from gross profit. It is a primary indicator of the segment's ability to generate sustainable earnings from its proprietary pharmaceutical portfolio.
Ask your AI about Amneal Pharmaceuticals, Inc.'s specialty — operating income (loss).
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude